Correspondence 0001193125-23-028450 from Comera Life Sciences Holdings, Inc. (CMRA) (CIK 0001907685)
Comera Life Sciences Holdings, Inc. (CMRA) (CIK 0001907685)
Date: Feb. 8, 2023 · CIK: 0001907685 · Accession: 0001193125-23-028450
AI Filing Summary & Sentiment
File numbers found in text: 333-269564
Letter
Comera Life Sciences Holdings, Inc.
12 Gill Street, Suite 4650
Woburn, Massachusetts 01801
February 8, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Comera Life Sciences Holdings, Inc.
Registration Statement on Form S-1
File No. 333-269564
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Comera Life Sciences Holdings, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-1, as amended (File No. 333-269564) so that it may become effective at 4:00 p.m. Eastern time on February 10, 2023, or as soon thereafter as practicable.
[Remainder of this page intentionally left blank]
Very truly yours,
Comera Life Sciences Holdings, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Comera Life Sciences Holdings, Inc. 12 Gill Street, Suite 4650 Woburn, Massachusetts 01801 February 8, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Comera Life Sciences Holdings, Inc. Registration Statement on Form S-1 File No. 333-269564 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Comera Life Sciences Holdings, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-1, as amended (File No. 333-269564) so that it may become effective at 4:00 p.m. Eastern time on February 10, 2023, or as soon thereafter as practicable. [Remainder of this page intentionally left blank] Very truly yours, Comera Life Sciences Holdings, Inc. By: /s/ Jeffrey S. Hackman Name: Jeffrey S. Hackman Title: Chairman, President and CEO